Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Artemisinin therapeutic efficacy in the experimental model of multiple sclerosis

Published:2017-09-27 Issue:6 Volume:39 Page:348-353
ISSN:0892-3973
Container-title:Immunopharmacology and Immunotoxicology
language:en
Short-container-title:Immunopharmacology and Immunotoxicology

Author:

Khakzad Mohammad Reza¹²,Ganji Ali³⁴^ORCID,Ariabod Vahid⁵,Farahani Iman³⁴

Affiliation:

1. Innovative Medical Research Center, Department of Immunology, Mashhad Branch, Islamic Azad University, Mashhad, Iran;

2. Allergy Research Center, Mashhad, University of Medical Sciences, Mashhad, Iran;

3. Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran;

4. Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran;

5. Department of Pathology, Mashhad Branch, Islamic Azad University, Mashhad, Iran

Funder

Islamic Azad University

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/08923973.2017.1379087

Reference23 articles.

1. Experimental autoimmune encephalomyelitis in the rat: lessons in T-cell immunology and autoreactivity

2. A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB study

3. Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis

4. US FDA-Approved Disease-Modifying Treatments for Multiple Sclerosis

5. Isolation of high artemisinin-yielding clones of Artemisia annua

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artemisinin and its derivatives as promising therapies for autoimmune diseases;Heliyon;2024-04

2. Dihydroartemisinin Regulated the MMP-Mediated Cellular Microenvironment to Alleviate Rheumatoid Arthritis;Research;2024-01

3. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases;Medicinal Research Reviews;2023-12-06

4. The novel small molecule TPN10518 alleviates EAE pathogenesis by inhibiting AP1 to depress Th1/Th17 cell differentiation;International Immunopharmacology;2023-10

5. Tehranolid and Artemisinin Effects on Ameliorating Experimental Autoimmune Encephalomyelitis by Modulating Inflammation and Remyelination;Molecular Neurobiology;2023-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3